he findings were presented this week at an infectious diseases conference in Washington, D.C.
"Our research shows that routine pneumococcal vaccination is a proactive approach that can greatly reduce the effects of a future flu pandemic," Klugman said. "Countries that have not yet implemented a pneumococcal vaccination program may want to consider this as part of their pandemic flu preparedness."
Klugman is a paid consultant for Wyeth Pharmaceuticals, which funded the study.
More information
The Immunization Action Coalition has more about pneumococcal diseases.
-- Robert Preidt
SOURCE: Emory University, news release, Oct. 28, 2008
'/>"/>Copyright©2008 ScoutNews,LLC. All rights reserved | |
Page: 1 2 Related medicine news :1.
DNA vaccine against multiple sclerosis appears safe, potentially beneficial2.
HPV vaccine does not appear to be effective for treating pre-existing HPV infection3.
Vaccine Stops Alzheimers Brain Tangles4.
Human Papilloma Virus vaccines may decrease chances of oral cancer5.
U.S. Teens Fall Short on Vaccine Coverage6.
Nasal Anthrax Vaccine Proves Effective in Animal Study7.
Hot ice, measuring depression, perfect invisibility and flu vaccine incentives8.
Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine9.
Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study10.
FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr11.
MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production